Intranasal Midazolam for Preanasthetic Sedation for Preschool Children Undergoing Adenotonsillectomy.

Sohag University100 enrolled

Overview

This study aims to evaluate the effectiveness of Intranasal Midazolam as preanasthetic sedation for preschool children (2-6)y undergoing adenotonsillectomy.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

100

Conditions

Adenotonsillar Hypertrophy

Interventions

intranasal normal saline for preanasthetic sedation for AdenotonsillectomyDRUG

preschool children that will undergo adenotonsillectomy will receive intranasal normal saline equivalent volume who take midazolam intranasal by dose 1 ml saline by insulin syringe as a control group

intranasal midazolam for preanasthetic sedation for AdenotonsillectomyDRUG

preschool children that will undergo adenotonsillectomy will receive intranasal midazolam by dose 0.2 mg/kg

Eligibility

Sex: ALLMin age: 2 YearsMax age: 6 Years

Medical Language ↔ Plain English

Inclusion Criteria: * pediatric patient of age 2-6 y * ASA I-II children * child scheduled for elective adenoidectomy , tonsillectomy and adenotonsillectomy Exclusion Criteria: * Parent refusal . * Allergy to any of the drug included in this study * Nasal infection , allergy and pathology * Mentally affected children , neurological disable . * Blood disesases and any other contraindications of surgery

Locations (1)

Sohag University Hospital

Sohag, Egypt

RECRUITING

Outcomes

Primary Outcomes

sedative effect of preanesthetic Midazolam

Glasgow coma scale

Time frame: 5 minutes,10 minutes and 15 minutes preoperative

Central Contacts

Mohamed R Hassan, Resident

CONTACT

01012552154 mohamedmiro165@gmail.com

Ahmed E Abdelrahman, Professor

CONTACT

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.